SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:16987df5-29de-4712-a7c3-3b6d9494b540"
 

Search: onr:"swepub:oai:lup.lub.lu.se:16987df5-29de-4712-a7c3-3b6d9494b540" > Anti-beta 2 glycopr...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00006682naa a2200841 4500
001oai:lup.lub.lu.se:16987df5-29de-4712-a7c3-3b6d9494b540
003SwePub
008210528s2021 | |||||||||||000 ||eng|
024a https://lup.lub.lu.se/record/16987df5-29de-4712-a7c3-3b6d9494b5402 URI
024a https://doi.org/10.1177/096120332110142482 DOI
040 a (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
100a Elkhalifa, Marwau Johns Hopkins University School of Medicine,Alexandria University4 aut
2451 0a Anti-beta 2 glycoprotein I IgA in the SLICC classification criteria dataset
264 c 2021-05-06
264 1b SAGE Publications,c 2021
300 a 6 s.
520 a Objective: Anti-beta 2 glycoprotein I IgA is a common isotype of anti-beta 2 glycoprotein I in SLE. Anti-beta 2 glycoprotein I was not included in the American College of Rheumatology (ACR) SLE classification criteria, but was included in the Systemic Lupus International Collaborating Clinics (SLICC) criteria. We aimed to evaluate the prevalence of anti-beta 2-glycoprotein I IgA in SLE versus other rheumatic diseases. In addition, we examined the association between anti-beta 2 glycoprotein I IgA and disease manifestations in SLE. Methods: The dataset consisted of 1384 patients, 657 with a consensus physician diagnosis of SLE and 727 controls with other rheumatic diseases. Anti-beta 2 glycoprotein I isotypes were measured by ELISA. Patients with a consensus diagnosis of SLE were compared to controls with respect to presence of anti-beta 2 glycoprotein I. Among patients with SLE, we assessed the association between anti-beta 2 glycoprotein I IgA and clinical manifestations. Results: The prevalence of anti-beta 2 glycoprotein I IgA was 14% in SLE patients and 7% in rheumatic disease controls (odds ratio, OR 2.3, 95% CI: 1.6, 3.3). It was more common in SLE patients who were younger patients and of African descent (p = 0.019). Eleven percent of SLE patients had anti-beta 2 glycoprotein I IgA alone (no anti-beta 2 glycoprotein I IgG or IgM). There was a significant association between anti-beta 2 glycoprotein I IgA and anti-dsDNA (p = 0.001) and the other antiphospholipid antibodies (p = 0.0004). There was no significant correlation of anti-beta 2 glycoprotein I IgA with any of the other ACR or SLICC clinical criteria for SLE. Those with anti-beta 2 glycoprotein I IgA tended to have a history of thrombosis (12% vs 6%, p = 0.071), but the difference was not statistically significant. Conclusion: We found the anti-beta 2 glycoprotein I IgA isotype to be more common in patients with SLE and in particular, with African descent. It could occur alone without other isotypes.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Reumatologi och inflammation0 (SwePub)302102 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Rheumatology and Autoimmunity0 (SwePub)302102 hsv//eng
653 a anti-beta 2 glycoprotein IgA
653 a antiphospholipid antibodies
653 a classification criteria
653 a Systemic lupus erythematosus
700a Orbai, Ana Mariau Johns Hopkins University School of Medicine4 aut
700a Magder, Laurence S.u University of Maryland School of Medicine4 aut
700a Petri, Michelleu Johns Hopkins University School of Medicine4 aut
700a Alarcón, Graciela S.u University of Alabama4 aut
700a Gordon, Carolineu University of Birmingham4 aut
700a Merrill, Joanu Oklahoma Medical Research Foundation4 aut
700a Fortin, Paul R.u Laval University4 aut
700a Bruce, Ian N.4 aut
700a Isenberg, Davidu University College London4 aut
700a Wallace, Danielu University of California, Los Angeles4 aut
700a Nived, Olau Lund University,Lunds universitet,Reumatologi och molekylär skelettbiologi,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Rheumatology,Section III,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)reum-oni
700a Ramsey-Goldman, Rosalindu Northwestern University Feinberg School of Medicine4 aut
700a Bae, Sang Cheolu Hanyang University4 aut
700a Hanly, John G.u Dalhousie University4 aut
700a Sanchez-Guerrero, Jorgeu University of Toronto4 aut
700a Clarke, Ann E.4 aut
700a Aranow, Cynthiau Feinstein Institute for Medical Research4 aut
700a Manzi, Susanu Allegheny Health Network4 aut
700a Urowitz, Murrayu University of Toronto4 aut
700a Gladman, Dafna D.u University of Toronto4 aut
700a Kalunian, Kenu University of California, San Diego4 aut
700a Werth, Victoria P.u Hospital of the University of Pennsylvania4 aut
700a Zoma, Asadu Hairmyres Hospital4 aut
700a Bernatsky, Sashau McGill University Health Center4 aut
700a Khamashta, Munther4 aut
700a Jacobsen, SØrenu Copenhagen University Hospital4 aut
700a Buyon, Jill P.u New York University4 aut
700a Dooley, Mary Anneu University of North Carolina4 aut
700a Vollenhoven, Ronald vanu Academic Medical Center of University of Amsterdam (AMC),Vrije Universiteit Amsterdam4 aut
700a Ginzler, Ellenu SUNY Downstate Health Sciences University4 aut
700a Stoll, Thomasu Cantonal Hospital of Olten4 aut
700a Peschken, Christineu University of Manitoba4 aut
700a Jorizzo, Joseph L.u Weill Cornell Medical College4 aut
700a Callen, Jeffery P.u University of Louisville Health Sciences Center4 aut
700a Lim, Samu Emory University4 aut
700a Inanc, Murat4 aut
700a Kamen, Diane L.u Medical University of South Carolina4 aut
700a Rahman, Anisuru University College London4 aut
700a Steinsson, Kristjanu National University Hospital of Iceland4 aut
700a Franks, Andrew G.u New York University4 aut
710a Johns Hopkins University School of Medicineb Alexandria University4 org
773t Lupusd : SAGE Publicationsg 30:8, s. 1283-1288q 30:8<1283-1288x 0961-2033x 1477-0962
856u http://dx.doi.org/10.1177/09612033211014248y FULLTEXT
856u https://discovery.ucl.ac.uk/10131180/3/Isenberg_Anti-beta%202%20glycoprotein%20I%20IgA%20in%20the%20SLICC%20classification%20criteria%20dataset_AAM.pdf
8564 8u https://lup.lub.lu.se/record/16987df5-29de-4712-a7c3-3b6d9494b540
8564 8u https://doi.org/10.1177/09612033211014248

Find in a library

  • Lupus (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view